Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Cancer Medicine|October 24, 2017
Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimenAlaa M Ali, Daniel Weisel, Feng Gao, et al.
Cell|October 23, 2018
High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer TherapyMatthew M Gubin, Ekaterina Esaulova, Jeffrey P Ward, et al.
Future Oncology (London, England)|January 11, 2021
MOMENTUM: momelotinib vs danazol in patients with myelofibrosis previously treated with JAKi who are symptomatic and anemicSrdan Verstovsek, Chih-Cheng Chen, Miklós Egyed, et al.
NEJM Evidence|August 26, 2025
Pemigatinib for Myeloid/Lymphoid Neoplasms with FGFR1 RearrangementSrdan Verstovsek, Jean-Jacques Kiladjian, Alessandro M Vannucchi, et al.
The New England Journal of Medicine|May 10, 2013
Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CMLJulia E Maxson, Jason Gotlib, Daniel A Pollyea, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 4, 2024
Meaningful Symptomatic Change in Patients With Myelofibrosis From the SIMPLIFY StudiesStacie Hudgens, Srdan Verstovsek, Lysbeth Floden, et al.
Hemasphere|October 30, 2023
Patient-reported Outcomes and Quality of Life in Anemic and Symptomatic Patients With Myelofibrosis: Results From the MOMENTUM StudyRuben A Mesa, Claire Harrison, Jeanne M Palmer, et al.
Cancer Medicine|April 6, 2023
Symptomatic benefit of momelotinib in patients with myelofibrosis: Results from the SIMPLIFY phase III studiesRuben A Mesa, Stacie Hudgens, Lysbeth Floden, et al.
Blood|June 25, 2026
Galectin-1 Fuels Monocyte Hyperinflammation and Represents a Novel Therapeutic Target in Myeloproliferative NeoplasmsFan He, Shuyang Lin, Tim Kong, et al.
Cancer Research|October 23, 2012
Kinase pathway dependence in primary human leukemias determined by rapid inhibitor screeningJeffrey W Tyner, Wayne F Yang, Armand Bankhead, et al.
Pageof 10